ArticleJournal of responsible innovation2021
Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.
Article in Journal of responsible innovation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Dutch Christian Faith Leaders Deliberating Human Germline Gene Editing: A Qualitative Study.Journal of religion and health · 2026Article
- Imagining Genomics and Population Health in 2050: Anticipating Future Research, Policy, and Governance Needs.Public health genomics · 2026Article
- A decade of public engagement regarding human germline gene editing: a systematic scoping review.European journal of human genetics : EJHG · 2025Article
- Anticipatory gaps challenge the public governance of heritable human genome editing.Journal of medical ethics · 2025Article
- CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges.Frontiers in neurology · 2025Review
- Preventive Human Genome Editing and Enhancement: Candidate Criteria for Governance.The Hastings Center report · 2024Article
- Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing.The CRISPR journal · 2024Article
- Beyond the traditional distinctions of genome editing: evaluating a vulnerability framework.Frontiers in genome editing · 2024Article
- Human Heritable Genome Editing and its Governance: Views of Scientists and Governance Professionals.New genetics and society · 2024Article
- The technology, opportunities, and challenges of Synthetic Biological Intelligence.Biotechnology advances · 2023Review
- Researching the future: scenarios to explore the future of human genome editing.BMC medical ethics · 2023Article
- Review
- The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research.The American journal of bioethics : AJOB · 2023Article
- Scientists' Views on Scientific Self-Governance for Human Genome Editing Research.Human gene therapy · 2022Article
- Amplifying the call for anticipatory governance.The American journal of bioethics : AJOB · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rapid development of human genome editing (HGE) techniques evokes an urgent need for forward-looking deliberation regarding the aims, processes, and governance of research. The framework of anticipatory governance (AG) may serve this need. This article reviews scholarly discourse about HGE through an AG lens, aiming to identify gaps in discussion and practice and suggest how AG efforts may fill them. Discourse on HGE has insufficiently reckoned with the institutional and systemic contexts, inputs, and implications of HGE work, to the detriment of its ability to prepare for a variety of possible futures and pursue socially desirable ones. More broadly framed and inclusive efforts in foresight and public engagement, focused not only upon the in-principle permissibility of HGE activities but upon the contexts of such work, may permit improved identification of public values relevant to HGE and of actions by which researchers, funders, policymakers, and publics may promote them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.